Can an Imaging-guided Pathway Replace the Current Paradigm for Muscle-invasive Bladder Cancer?
- PMID: 33840560
- DOI: 10.1016/j.eururo.2021.03.018
Can an Imaging-guided Pathway Replace the Current Paradigm for Muscle-invasive Bladder Cancer?
Comment in
-
Reply to Trey Durdin, Alvin Goh, and Eugene Pietzak. Can an Imaging-guided Pathway Replace the Current Paradigm for Muscle-invasive Bladder Cancer?Eur Urol. 2021 Jul;80(1):18-19. doi: 10.1016/j.eururo.2021.04.034. Epub 2021 May 8. Eur Urol. 2021. PMID: 33972095 No abstract available.
-
Re: Trey Durdin, Alvin Goh, Eugene Pietzak. Can an Imaging-guided Pathway Replace the Current Paradigm for Muscle-invasive Bladder Cancer? Eur Urol 2021;80:16-7: Transurethral Resection of Bladder Tumor in Diagnosis of Muscle-invasive Bladder Cancer: Old-fashioned Endoscopic Surgery is Here to Stay.Eur Urol. 2022 Apr;81(4):e94-e95. doi: 10.1016/j.eururo.2021.12.034. Epub 2022 Jan 12. Eur Urol. 2022. PMID: 35031161 No abstract available.
Comment on
-
Comparing an Imaging-guided Pathway with the Standard Pathway for Staging Muscle-invasive Bladder Cancer: Preliminary Data from the BladderPath Study.Eur Urol. 2021 Jul;80(1):12-15. doi: 10.1016/j.eururo.2021.02.021. Epub 2021 Feb 27. Eur Urol. 2021. PMID: 33653635
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
